Federico Mauri
Company: Boehringer Ingelheim
Job title: Priincipal Scientist
Seminars:
Per Aspera Ad Astra: The Potential of Hippo Pathway inhibition as a Mono- & Combination Therapy Concept 8:30 am
Download the Brochure to View the Session DetailsRead more
day: Day One Morning